{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:13:17Z","timestamp":1773281597500,"version":"3.50.1"},"reference-count":21,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2009,1,31]],"date-time":"2009-01-31T00:00:00Z","timestamp":1233360000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acta Ophthalmologica"],"published-print":{"date-parts":[[2009,5]]},"abstract":"<jats:title>Abstract.<\/jats:title><jats:p><jats:bold>Purpose:\u2002<\/jats:bold> This study compared the post\u2010cataract surgery anti\u2010inflammatory effects of topical treatment with 0.1% bromfenac, 0.1% betamethasone or both on postoperative anterior chamber inflammation and corneal swelling.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> Seventy\u2010two patients with no eye disease other than cataract were enrolled in a prospective, randomized study to undergo phacoemulsification combined with intraocular lens implantation. After cataract surgery, patients were randomized to treatment with bromfenac, betamethasone or both agents. Twenty\u2010five eyes were assigned to bromfenac, 23 to betamethasone and 24 to the combined treatment group. Inflammatory reactions in the anterior chamber were measured with laser flare photometry preoperatively and at 1 and 3\u2003days, 1 and 2\u2003weeks, and 1 and 2\u2003months postoperatively. Intraocular pressure (IOP) and corneal thickness were measured at the same time\u2010points. Best corrected visual acuity (BCVA) was measured preoperatively and at 2\u2003days, 1 and 2\u2003weeks, and 1 and 2\u2003months postoperatively. Specular microscope endothelial photography of the central region of the cornea was performed preoperatively and at 3\u2003months after surgery.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> There were no significant differences among the bromfenac, betamethasone and combined treatment groups in BCVA, IOP, aqueous flare or corneal thickness. Cystoid macular oedema was present in one eye treated with betamethasone.<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold> There were no significant differences in anti\u2010inflammatory effects among the three treatments. These findings suggest that bromfenac is as effective as betamethasone in minimizing inflammatory reactions after cataract surgery.<\/jats:p>","DOI":"10.1111\/j.1755-3768.2008.01433.x","type":"journal-article","created":{"date-parts":[[2009,1,31]],"date-time":"2009-01-31T17:36:43Z","timestamp":1233423403000},"page":"300-305","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Effect of bromfenac ophthalmic solution on ocular inflammation following cataract surgery"],"prefix":"10.1111","volume":"87","author":[{"given":"Masaru","family":"Miyanaga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Miyai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryohei","family":"Nejima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,4,17]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/278456a0"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(00)00538-8"},{"key":"e_1_2_5_4_1","first-page":"433","volume-title":"Ocular Pharmacology","author":"Havener WH","year":"1983"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0420.2000.078004421.x"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0886-3350(97)80313-6"},{"key":"e_1_2_5_7_1","first-page":"286","article-title":"Comparison of postoperative inflammation with two types of intraocular lens and anti\u2010inflammatory agents","volume":"49","author":"Kato S","year":"1998","journal-title":"Folia Ophthalmol Jpn"},{"key":"e_1_2_5_8_1","first-page":"276","article-title":"Effect of bromfenac ophthalmic solution on ocular inflammation and corneal epithelial barrier function following cataract surgery","volume":"54","author":"Kawaguchi T","year":"2003","journal-title":"Folia Ophthalmol Jpn"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1990.01070050078035"},{"key":"e_1_2_5_10_1","first-page":"819","article-title":"Anti\u2010inflammatory agents and inhibition of ocular prostaglandin synthetase","volume":"2","author":"Ku EC","year":"1976","journal-title":"Adv Prostaglandin Thromboxane Res"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.86.12.1380"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0420.1998.760512.x"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2004.12.080"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1990.01070140118041"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-5155(99)00176-8"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.1993.tb04967.x"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1045766"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0886-3350(13)80036-3"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0886-3350(96)80160-X"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0886-3350(96)80164-7"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-005-0124-2"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(96)30732-X"}],"container-title":["Acta Ophthalmologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1755-3768.2008.01433.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1755-3768.2008.01433.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T17:28:36Z","timestamp":1697045316000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1755-3768.2008.01433.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,17]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["10.1111\/j.1755-3768.2008.01433.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1755-3768.2008.01433.x","archive":["Portico"],"relation":{},"ISSN":["1755-375X","1755-3768"],"issn-type":[{"value":"1755-375X","type":"print"},{"value":"1755-3768","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,17]]},"assertion":[{"value":"2009-04-17","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}